Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Real-time analysis of a mass vaccination effort confirms the safety of FDA-authorized mRNA COVID-19 vaccines
Reid McMurry, Patrick J. Lenehan, Samir Awasthi, et al.
Med (2021) Vol. 2, Iss. 8, pp. 965-978.e5
Open Access | Times Cited: 60

Showing 1-25 of 60 citing articles:

Effectiveness and safety of SARS-CoV-2 vaccine in real-world studies: a systematic review and meta-analysis
Qiao Liu, Chenyuan Qin, Min Liu, et al.
Infectious Diseases of Poverty (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 321
Comparison of two highly-effective mRNA vaccines for COVID-19 during periods of Alpha and Delta variant prevalence
Arjun Puranik, Patrick J. Lenehan, Eli Silvert, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 228
Evaluation of the safety profile of COVID-19 vaccines: a rapid review
Qianhui Wu, Matthew Z. Dudley, Xinghui Chen, et al.
BMC Medicine (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 215
Reported COVID-19 vaccines side effects among Jordanian population: a cross sectional study
Haya Omeish, Angam Najadat, Sayer Al‐Azzam, et al.
Human Vaccines & Immunotherapeutics (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 82
Analysis of the Effectiveness of the Ad26.COV2.S Adenoviral Vector Vaccine for Preventing COVID-19
Juan Corchado-Garcia, David Zemmour, Travis Hughes, et al.
JAMA Network Open (2021) Vol. 4, Iss. 11, pp. e2132540-e2132540
Open Access | Times Cited: 82
Artificial Intelligence in Surveillance, Diagnosis, Drug Discovery and Vaccine Development against COVID-19
Gunjan Arora, Jayadev Joshi, Rahul Shubhra Mandal, et al.
Pathogens (2021) Vol. 10, Iss. 8, pp. 1048-1048
Open Access | Times Cited: 75
Comparison of Two Highly-Effective mRNA Vaccines for COVID-19 During Periods of Alpha and Delta Variant Prevalence
Arjun Puranik, Patrick J. Lenehan, Eli Silvert, et al.
SSRN Electronic Journal (2021)
Open Access | Times Cited: 75
The Implementation of Mass-Vaccination against SARS-CoV-2: A Systematic Review of Existing Strategies and Guidelines
Tasnim Hasan, Justin Beardsley, Ben J. Marais, et al.
Vaccines (2021) Vol. 9, Iss. 4, pp. 326-326
Open Access | Times Cited: 74
A longitudinal study of vaccine hesitancy attitudes and social influence as predictors of COVID-19 vaccine uptake in the US
Carl A. Latkin, Lauren Dayton, Jacob Miller, et al.
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 5
Open Access | Times Cited: 65
Association of SARS-CoV-2 Vaccination or Infection With Bell Palsy
Ali Rafati, Yeganeh Pasebani, Melika Jameie, et al.
JAMA Otolaryngology–Head & Neck Surgery (2023) Vol. 149, Iss. 6, pp. 493-493
Open Access | Times Cited: 26
Lymphadenopathy post‐COVID‐19 vaccination with increased FDG uptake may be falsely attributed to oncological disorders: A systematic review
Khalifa Bshesh, Wafa Khan, Ahamed Lazim Vattoth, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 5, pp. 1833-1845
Open Access | Times Cited: 32
Surveillance of Safety of 3 Doses of COVID-19 mRNA Vaccination Using Electronic Health Records
Michiel J.M. Niesen, Colin Pawlowski, John C. O’Horo, et al.
JAMA Network Open (2022) Vol. 5, Iss. 4, pp. e227038-e227038
Open Access | Times Cited: 29
COVID-19 Vaccines, Effectiveness, and Immune Responses
Haneen I. Abufares, Leen Oyoun Alsoud, Mohammad A. Y. Alqudah, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 15415-15415
Open Access | Times Cited: 28
COVID-19, Vaccines, and Thrombotic Events: A Narrative Review
Maurizio Giuseppe Abrignani, Adriano Murrone, Leonardo De Luca, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 4, pp. 948-948
Open Access | Times Cited: 27
Neurological Immune‐Related Adverse Events After COVID‐19 Vaccination: A Systematic Review
Ameena Shafiq, Mohammad Salameh, Ibrahim Laswi, et al.
The Journal of Clinical Pharmacology (2021) Vol. 62, Iss. 3, pp. 291-303
Open Access | Times Cited: 30
Safety of COVID-19 vaccination and acute neurological events: A self-controlled case series in England using the OpenSAFELY platform
Jemma Walker, Anna Schultze, John Tazare, et al.
Vaccine (2022) Vol. 40, Iss. 32, pp. 4479-4487
Open Access | Times Cited: 22
Safety and Adverse Events Related to COVID-19 mRNA Vaccines; a Systematic Review.
SeyedAhmad SeyedAlinaghi, Amirali Karimi, Zahra Pashaei, et al.
PubMed (2022) Vol. 10, Iss. 1, pp. e41-e41
Closed Access | Times Cited: 21
Moving towards vertically integrated artificial intelligence development
Joe Zhang, Sanjay Budhdeo, William Wasswa, et al.
npj Digital Medicine (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 21
Comparative effectiveness of mRNA-1273 and BNT162b2 against symptomatic SARS-CoV-2 infection
Arjun Puranik, Patrick J. Lenehan, Eli Silvert, et al.
Med (2021) Vol. 3, Iss. 1, pp. 28-41.e8
Open Access | Times Cited: 27
Safety of Global SARS-CoV-2 Vaccines, a Meta-Analysis
Linyi Chen, Xianming Cai, Tianshuo Zhao, et al.
Vaccines (2022) Vol. 10, Iss. 4, pp. 596-596
Open Access | Times Cited: 19
Effectiveness of pentavalent rotavirus vaccine — a propensity score matched test negative design case-control study using electronic health records in three provinces of China
Yuexin Xiu, Lin Tang, Fuzhen Wang, et al.
Research Square (Research Square) (2025)
Open Access
Facial Nerve Palsy Amid the SARS-CoV-2 Pandemic: A Pooled Analysis
Ahmad A. Mirza, Abdulaziz H. Almalki, Faisal A. Noori, et al.
Journal of Otolaryngology - Head and Neck Surgery (2025) Vol. 54
Open Access
Case Report: Vaccine-Induced Immune Thrombotic Thrombocytopenia in a Pancreatic Cancer Patient After Vaccination With Messenger RNA−1273
Po-Hsu Su, Yi-Ching Yu, Wen‐Hsin Chen, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 23
Impact of a delayed second dose of mRNA vaccine (BNT162b2) and inactivated SARS-CoV-2 vaccine (CoronaVac) on risks of all-cause mortality, emergency department visit, and unscheduled hospitalization
Carlos King Ho Wong, Xi Xiong, Kristy T. K. Lau, et al.
BMC Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 15
The association between service experience in vaccination centers and expectation confirmation as a driver of future vaccination intentions: Results from a survey among users of a Swiss mass COVID-19 vaccination center
Frank Mattes, Julia Dratva, Sarah Schmelzer, et al.
Vaccine (2024) Vol. 43, pp. 126509-126509
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top